Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review

<h3>Background</h3><p dir="ltr">Prevalence of diabetes has steadily increased over the last few decades with 1.5 million deaths reported in 2012 alone. Traditionally, analyzing patients with diabetes has remained a largely invasive approach. Wearable devices (WDs) make us...

Full description

Saved in:
Bibliographic Details
Main Author: Arfan Ahmed (17541309) (author)
Other Authors: Sarah Aziz (17541312) (author), Alaa Abd-alrazaq (17058018) (author), Faisal Farooq (13134579) (author), Javaid Sheikh (5534825) (author)
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513518620901376
author Arfan Ahmed (17541309)
author2 Sarah Aziz (17541312)
Alaa Abd-alrazaq (17058018)
Faisal Farooq (13134579)
Javaid Sheikh (5534825)
author2_role author
author
author
author
author_facet Arfan Ahmed (17541309)
Sarah Aziz (17541312)
Alaa Abd-alrazaq (17058018)
Faisal Farooq (13134579)
Javaid Sheikh (5534825)
author_role author
dc.creator.none.fl_str_mv Arfan Ahmed (17541309)
Sarah Aziz (17541312)
Alaa Abd-alrazaq (17058018)
Faisal Farooq (13134579)
Javaid Sheikh (5534825)
dc.date.none.fl_str_mv 2022-08-09T03:00:00Z
dc.identifier.none.fl_str_mv 10.2196/36010
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Overview_of_Artificial_Intelligence_Driven_Wearable_Devices_for_Diabetes_Scoping_Review/25671651
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Health sciences
Health services and systems
diabetes
artificial intelligence
wearable devices
machine learning
mobile phone
dc.title.none.fl_str_mv Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p dir="ltr">Prevalence of diabetes has steadily increased over the last few decades with 1.5 million deaths reported in 2012 alone. Traditionally, analyzing patients with diabetes has remained a largely invasive approach. Wearable devices (WDs) make use of sensors historically reserved for hospital settings. WDs coupled with artificial intelligence (AI) algorithms show promise to help understand and conclude meaningful information from the gathered data and provide advanced and clinically meaningful analytics.</p><h3>Objective</h3><p dir="ltr">This review aimed to provide an overview of AI-driven WD features for diabetes and their use in monitoring diabetes-related parameters.</p><h3>Methods</h3><p dir="ltr">We searched 7 of the most popular bibliographic databases using 3 groups of search terms related to diabetes, WDs, and AI. A 2-stage process was followed for study selection: reading abstracts and titles followed by full-text screening. Two reviewers independently performed study selection and data extraction, and disagreements were resolved by consensus. A narrative approach was used to synthesize the data.</p><h3>Results</h3><p dir="ltr">From an initial 3872 studies, we report the features from 37 studies post filtering according to our predefined inclusion criteria. Most of the studies targeted type 1 diabetes, type 2 diabetes, or both (21/37, 57%). Many studies (15/37, 41%) reported blood glucose as their main measurement. More than half of the studies (21/37, 57%) had the aim of estimation and prediction of glucose or glucose level monitoring. Over half of the reviewed studies looked at wrist-worn devices. Only 41% of the study devices were commercially available. We observed the use of multiple sensors with photoplethysmography sensors being most prevalent in 32% (12/37) of studies. Studies reported and compared >1 machine learning (ML) model with high levels of accuracy. Support vector machine was the most reported (13/37, 35%), followed by random forest (12/37, 32%).</p><h3>Conclusions</h3><p dir="ltr">This review is the most extensive work, to date, summarizing WDs that use ML for people with diabetes, and provides research direction to those wanting to further contribute to this emerging field. Given the advancements in WD technologies replacing the need for invasive hospital setting devices, we see great advancement potential in this domain. Further work is needed to validate the ML approaches on clinical data from WDs and provide meaningful analytics that could serve as data gathering, monitoring, prediction, classification, and recommendation devices in the context of diabetes.</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Medical Internet Research<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.2196/36010" target="_blank">https://dx.doi.org/10.2196/36010</a></p>
eu_rights_str_mv openAccess
id Manara2_dae0f0ecee9b884f7af277517b5da570
identifier_str_mv 10.2196/36010
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25671651
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping ReviewArfan Ahmed (17541309)Sarah Aziz (17541312)Alaa Abd-alrazaq (17058018)Faisal Farooq (13134579)Javaid Sheikh (5534825)Health sciencesHealth services and systemsdiabetesartificial intelligencewearable devicesmachine learningmobile phone<h3>Background</h3><p dir="ltr">Prevalence of diabetes has steadily increased over the last few decades with 1.5 million deaths reported in 2012 alone. Traditionally, analyzing patients with diabetes has remained a largely invasive approach. Wearable devices (WDs) make use of sensors historically reserved for hospital settings. WDs coupled with artificial intelligence (AI) algorithms show promise to help understand and conclude meaningful information from the gathered data and provide advanced and clinically meaningful analytics.</p><h3>Objective</h3><p dir="ltr">This review aimed to provide an overview of AI-driven WD features for diabetes and their use in monitoring diabetes-related parameters.</p><h3>Methods</h3><p dir="ltr">We searched 7 of the most popular bibliographic databases using 3 groups of search terms related to diabetes, WDs, and AI. A 2-stage process was followed for study selection: reading abstracts and titles followed by full-text screening. Two reviewers independently performed study selection and data extraction, and disagreements were resolved by consensus. A narrative approach was used to synthesize the data.</p><h3>Results</h3><p dir="ltr">From an initial 3872 studies, we report the features from 37 studies post filtering according to our predefined inclusion criteria. Most of the studies targeted type 1 diabetes, type 2 diabetes, or both (21/37, 57%). Many studies (15/37, 41%) reported blood glucose as their main measurement. More than half of the studies (21/37, 57%) had the aim of estimation and prediction of glucose or glucose level monitoring. Over half of the reviewed studies looked at wrist-worn devices. Only 41% of the study devices were commercially available. We observed the use of multiple sensors with photoplethysmography sensors being most prevalent in 32% (12/37) of studies. Studies reported and compared >1 machine learning (ML) model with high levels of accuracy. Support vector machine was the most reported (13/37, 35%), followed by random forest (12/37, 32%).</p><h3>Conclusions</h3><p dir="ltr">This review is the most extensive work, to date, summarizing WDs that use ML for people with diabetes, and provides research direction to those wanting to further contribute to this emerging field. Given the advancements in WD technologies replacing the need for invasive hospital setting devices, we see great advancement potential in this domain. Further work is needed to validate the ML approaches on clinical data from WDs and provide meaningful analytics that could serve as data gathering, monitoring, prediction, classification, and recommendation devices in the context of diabetes.</p><h2>Other Information</h2><p dir="ltr">Published in: Journal of Medical Internet Research<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.2196/36010" target="_blank">https://dx.doi.org/10.2196/36010</a></p>2022-08-09T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.2196/36010https://figshare.com/articles/journal_contribution/Overview_of_Artificial_Intelligence_Driven_Wearable_Devices_for_Diabetes_Scoping_Review/25671651CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/256716512022-08-09T03:00:00Z
spellingShingle Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
Arfan Ahmed (17541309)
Health sciences
Health services and systems
diabetes
artificial intelligence
wearable devices
machine learning
mobile phone
status_str publishedVersion
title Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
title_full Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
title_fullStr Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
title_full_unstemmed Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
title_short Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
title_sort Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review
topic Health sciences
Health services and systems
diabetes
artificial intelligence
wearable devices
machine learning
mobile phone